Intrapulmonary percussive ventilation improves the outcome of patients with acute exacerbation of chronic obstructive pulmonary disease using a helmet

Vittorio Antonaglia, Umberto Lucangelo, Walter A. Zin, Alberto Peratoner, Loredana De Simoni, Guido Capitanio, Sara Pascotto, Antonino Gullo

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

OBJECTIVE: To evaluate the effect of intrapulmonary percussive ventilation (IPV) by mouthpiece during noninvasive positive-pressure ventilation with helmet in patients with exacerbation of chronic obstructive pulmonary disease (COPD). DESIGN: Randomized clinical trial. SETTING: General intensive care unit, university hospital. PATIENTS: Forty patients with exacerbation of COPD ventilated with noninvasive positive-pressure ventilation by helmet were randomized to two different mucus clearance strategies: IPV (IPV group) vs. respiratory physiotherapy (Phys group). As historical control group, 40 patients receiving noninvasive positive pressure and ventilated by face mask treated with respiratory physiotherapy were studied. INTERVENTIONS: Two daily sessions of IPV (IPV group) or conventional respiratory physiotherapy (Phys group). MEASUREMENTS AND MAIN RESULTS: Physiologic variables were measured at entry in the intensive care unit, before and after the first session of IPV, and at discharge from the intensive care unit. Outcome variables (need for intubation, ventilatory assistance, length of intensive care unit stay, and complications) were also measured. All physiologic variables improved after IPV. At discharge from the intensive care unit, Paco2 was lower in the IPV group compared with the Phys and control groups (mean ± sd, 58 ± 5.4 vs. 64 ± 5.2 mm Hg, 67.4 ± 4.2 mm Hg, p <.01). Pao2/Fio2 was higher in IPV (274 ± 15) than the other groups (Phys, 218 ± 34; control, 237 ± 20; p <.01). In the IPV group, time of noninvasive ventilation (hrs) (median, 25th-75th percentile: 61, 60-71) and length of stay in the intensive care unit (days) (7, 6-8) were lower than other groups (Phys, 89, 82-96; control, 87, 75-91; p <.01; and Phys, 9, 8-9; control, 10, 9-11; p <.01). CONCLUSIONS: IPV treatment was feasible for all patients. Noninvasive positive-pressure ventilation by helmet associated with IPV reduces the duration of ventilatory treatment and intensive care unit stay and improves gas exchange at discharge from intensive care unit in patients with severe exacerbation of COPD.

Original languageEnglish
Pages (from-to)2940-2945
Number of pages6
JournalCritical Care Medicine
Volume34
Issue number12
DOIs
Publication statusPublished - Dec 2006

Fingerprint

Head Protective Devices
Chronic Obstructive Pulmonary Disease
Ventilation
Intensive Care Units
Positive-Pressure Respiration
Noninvasive Ventilation
Control Groups
Mucus
Masks
Intubation
Length of Stay
Randomized Controlled Trials

Keywords

  • Chronic respiratory failure
  • Helmet
  • Intrapulmonary percussive ventilation
  • Noninvasive ventilation
  • Pressure support ventilation
  • Respiratory physiotherapy

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Intrapulmonary percussive ventilation improves the outcome of patients with acute exacerbation of chronic obstructive pulmonary disease using a helmet. / Antonaglia, Vittorio; Lucangelo, Umberto; Zin, Walter A.; Peratoner, Alberto; De Simoni, Loredana; Capitanio, Guido; Pascotto, Sara; Gullo, Antonino.

In: Critical Care Medicine, Vol. 34, No. 12, 12.2006, p. 2940-2945.

Research output: Contribution to journalArticle

Antonaglia, Vittorio ; Lucangelo, Umberto ; Zin, Walter A. ; Peratoner, Alberto ; De Simoni, Loredana ; Capitanio, Guido ; Pascotto, Sara ; Gullo, Antonino. / Intrapulmonary percussive ventilation improves the outcome of patients with acute exacerbation of chronic obstructive pulmonary disease using a helmet. In: Critical Care Medicine. 2006 ; Vol. 34, No. 12. pp. 2940-2945.
@article{22fbe6c6e4384a888e573bd07e55a841,
title = "Intrapulmonary percussive ventilation improves the outcome of patients with acute exacerbation of chronic obstructive pulmonary disease using a helmet",
abstract = "OBJECTIVE: To evaluate the effect of intrapulmonary percussive ventilation (IPV) by mouthpiece during noninvasive positive-pressure ventilation with helmet in patients with exacerbation of chronic obstructive pulmonary disease (COPD). DESIGN: Randomized clinical trial. SETTING: General intensive care unit, university hospital. PATIENTS: Forty patients with exacerbation of COPD ventilated with noninvasive positive-pressure ventilation by helmet were randomized to two different mucus clearance strategies: IPV (IPV group) vs. respiratory physiotherapy (Phys group). As historical control group, 40 patients receiving noninvasive positive pressure and ventilated by face mask treated with respiratory physiotherapy were studied. INTERVENTIONS: Two daily sessions of IPV (IPV group) or conventional respiratory physiotherapy (Phys group). MEASUREMENTS AND MAIN RESULTS: Physiologic variables were measured at entry in the intensive care unit, before and after the first session of IPV, and at discharge from the intensive care unit. Outcome variables (need for intubation, ventilatory assistance, length of intensive care unit stay, and complications) were also measured. All physiologic variables improved after IPV. At discharge from the intensive care unit, Paco2 was lower in the IPV group compared with the Phys and control groups (mean ± sd, 58 ± 5.4 vs. 64 ± 5.2 mm Hg, 67.4 ± 4.2 mm Hg, p <.01). Pao2/Fio2 was higher in IPV (274 ± 15) than the other groups (Phys, 218 ± 34; control, 237 ± 20; p <.01). In the IPV group, time of noninvasive ventilation (hrs) (median, 25th-75th percentile: 61, 60-71) and length of stay in the intensive care unit (days) (7, 6-8) were lower than other groups (Phys, 89, 82-96; control, 87, 75-91; p <.01; and Phys, 9, 8-9; control, 10, 9-11; p <.01). CONCLUSIONS: IPV treatment was feasible for all patients. Noninvasive positive-pressure ventilation by helmet associated with IPV reduces the duration of ventilatory treatment and intensive care unit stay and improves gas exchange at discharge from intensive care unit in patients with severe exacerbation of COPD.",
keywords = "Chronic respiratory failure, Helmet, Intrapulmonary percussive ventilation, Noninvasive ventilation, Pressure support ventilation, Respiratory physiotherapy",
author = "Vittorio Antonaglia and Umberto Lucangelo and Zin, {Walter A.} and Alberto Peratoner and {De Simoni}, Loredana and Guido Capitanio and Sara Pascotto and Antonino Gullo",
year = "2006",
month = "12",
doi = "10.1097/01.CCM.0000248725.15189.7D",
language = "English",
volume = "34",
pages = "2940--2945",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Intrapulmonary percussive ventilation improves the outcome of patients with acute exacerbation of chronic obstructive pulmonary disease using a helmet

AU - Antonaglia, Vittorio

AU - Lucangelo, Umberto

AU - Zin, Walter A.

AU - Peratoner, Alberto

AU - De Simoni, Loredana

AU - Capitanio, Guido

AU - Pascotto, Sara

AU - Gullo, Antonino

PY - 2006/12

Y1 - 2006/12

N2 - OBJECTIVE: To evaluate the effect of intrapulmonary percussive ventilation (IPV) by mouthpiece during noninvasive positive-pressure ventilation with helmet in patients with exacerbation of chronic obstructive pulmonary disease (COPD). DESIGN: Randomized clinical trial. SETTING: General intensive care unit, university hospital. PATIENTS: Forty patients with exacerbation of COPD ventilated with noninvasive positive-pressure ventilation by helmet were randomized to two different mucus clearance strategies: IPV (IPV group) vs. respiratory physiotherapy (Phys group). As historical control group, 40 patients receiving noninvasive positive pressure and ventilated by face mask treated with respiratory physiotherapy were studied. INTERVENTIONS: Two daily sessions of IPV (IPV group) or conventional respiratory physiotherapy (Phys group). MEASUREMENTS AND MAIN RESULTS: Physiologic variables were measured at entry in the intensive care unit, before and after the first session of IPV, and at discharge from the intensive care unit. Outcome variables (need for intubation, ventilatory assistance, length of intensive care unit stay, and complications) were also measured. All physiologic variables improved after IPV. At discharge from the intensive care unit, Paco2 was lower in the IPV group compared with the Phys and control groups (mean ± sd, 58 ± 5.4 vs. 64 ± 5.2 mm Hg, 67.4 ± 4.2 mm Hg, p <.01). Pao2/Fio2 was higher in IPV (274 ± 15) than the other groups (Phys, 218 ± 34; control, 237 ± 20; p <.01). In the IPV group, time of noninvasive ventilation (hrs) (median, 25th-75th percentile: 61, 60-71) and length of stay in the intensive care unit (days) (7, 6-8) were lower than other groups (Phys, 89, 82-96; control, 87, 75-91; p <.01; and Phys, 9, 8-9; control, 10, 9-11; p <.01). CONCLUSIONS: IPV treatment was feasible for all patients. Noninvasive positive-pressure ventilation by helmet associated with IPV reduces the duration of ventilatory treatment and intensive care unit stay and improves gas exchange at discharge from intensive care unit in patients with severe exacerbation of COPD.

AB - OBJECTIVE: To evaluate the effect of intrapulmonary percussive ventilation (IPV) by mouthpiece during noninvasive positive-pressure ventilation with helmet in patients with exacerbation of chronic obstructive pulmonary disease (COPD). DESIGN: Randomized clinical trial. SETTING: General intensive care unit, university hospital. PATIENTS: Forty patients with exacerbation of COPD ventilated with noninvasive positive-pressure ventilation by helmet were randomized to two different mucus clearance strategies: IPV (IPV group) vs. respiratory physiotherapy (Phys group). As historical control group, 40 patients receiving noninvasive positive pressure and ventilated by face mask treated with respiratory physiotherapy were studied. INTERVENTIONS: Two daily sessions of IPV (IPV group) or conventional respiratory physiotherapy (Phys group). MEASUREMENTS AND MAIN RESULTS: Physiologic variables were measured at entry in the intensive care unit, before and after the first session of IPV, and at discharge from the intensive care unit. Outcome variables (need for intubation, ventilatory assistance, length of intensive care unit stay, and complications) were also measured. All physiologic variables improved after IPV. At discharge from the intensive care unit, Paco2 was lower in the IPV group compared with the Phys and control groups (mean ± sd, 58 ± 5.4 vs. 64 ± 5.2 mm Hg, 67.4 ± 4.2 mm Hg, p <.01). Pao2/Fio2 was higher in IPV (274 ± 15) than the other groups (Phys, 218 ± 34; control, 237 ± 20; p <.01). In the IPV group, time of noninvasive ventilation (hrs) (median, 25th-75th percentile: 61, 60-71) and length of stay in the intensive care unit (days) (7, 6-8) were lower than other groups (Phys, 89, 82-96; control, 87, 75-91; p <.01; and Phys, 9, 8-9; control, 10, 9-11; p <.01). CONCLUSIONS: IPV treatment was feasible for all patients. Noninvasive positive-pressure ventilation by helmet associated with IPV reduces the duration of ventilatory treatment and intensive care unit stay and improves gas exchange at discharge from intensive care unit in patients with severe exacerbation of COPD.

KW - Chronic respiratory failure

KW - Helmet

KW - Intrapulmonary percussive ventilation

KW - Noninvasive ventilation

KW - Pressure support ventilation

KW - Respiratory physiotherapy

UR - http://www.scopus.com/inward/record.url?scp=33751342621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751342621&partnerID=8YFLogxK

U2 - 10.1097/01.CCM.0000248725.15189.7D

DO - 10.1097/01.CCM.0000248725.15189.7D

M3 - Article

VL - 34

SP - 2940

EP - 2945

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 12

ER -